Literature DB >> 23983355

Evaluation of traditional medicines III: the mechanism of immune modulation by PHELA.

Makhotso Lekhooa1, Andrew Walubo, Jan J B Du Plessis, Motlalepula G Matsabisa.   

Abstract

PHELA is a herbal traditional medicine that is under development for use as an immune booster in immune compromised individuals. Therefore, the aim of this study was to determine PHELA's mechanism of action by observing for changes in cytokine profiles. Four groups of Sprague Dawley rats (n = 8) were treated daily and separately with normal-saline, cyclosporine-A, PHELA-only and PHELA+ cyclosporine-A. Thereafter, 4 animals from each group were sacrificed after 7 and 14 days of treatment. Serum Th1 cytokines (IL-2, IFN-γ and TNF-α) and Th2 cytokines (IL-4 and IL-10) were measured by ELISA. The concentrations of Th1 cytokines in the PHELA-only treated group were similar to the control group on days 7 and 14. However, the Th1 cytokines were higher in the PHELA+cyclosporine-A treated group compared to cyclosporine-A group, and cyclosporine-A concentrations were similar in both groups. These results show that PHELA did not stimulate Th1 cytokines of a normal immune system but stimulated them when the immune system was suppressed by cyclosporine-A. In conclusion, PHELA is an immune-stimulant to a compromised immune system.

Entities:  

Keywords:  PHELA; cyclosporine-A; cytokines; immune stimulant; traditional medicine

Mesh:

Substances:

Year:  2012        PMID: 23983355      PMCID: PMC3746612          DOI: 10.4314/ajtcam.v9i3s.7

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  25 in total

1.  Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients.

Authors:  J Alberú; Y Richaud-Patin; E Mancilla; H Díliz; R Correa-Rotter; A Chew-Wong; N Uribe; C de Leo; L Llorente
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Role of pro-inflammatory cytokines and beta-chemokines in controlling HIV replication.

Authors:  E Vicenzi; P Biswas; M Mengozzi; G Poli
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

3.  Mycophenolate mofetil as an alternative to cyclosporine in post renal transplant thrombocytopenia.

Authors:  Kishore Phadke; Arpana Bagirath
Journal:  Pediatr Nephrol       Date:  2004-05-13       Impact factor: 3.714

4.  Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.

Authors:  Mi-La Cho; Wan-Uk Kim; So-Youn Min; Do-June Min; Jun-Ki Min; Sang-Heon Lee; Sung-Hwan Park; Chul-Soo Cho; Ho-Youn Kim
Journal:  Arthritis Rheum       Date:  2002-01

5.  Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets.

Authors:  J E McElhaney; S Gravenstein; C M Upshaw; J W Hooton; P Krause; P Drinka
Journal:  Vaccine       Date:  1998-02       Impact factor: 3.641

6.  Recurrence of haemolytic uraemic syndrome triggered by cyclosporin A after renal transplantation.

Authors:  C Leithner; H Sinzinger; E Pohanka; M Schwarz; G Kretschmer; G Syre
Journal:  Lancet       Date:  1982-06-26       Impact factor: 79.321

Review 7.  The role of increased platelet aggregation in TTP.

Authors:  E C Lian
Journal:  Semin Thromb Hemost       Date:  1980       Impact factor: 4.180

8.  Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

Authors:  M Saurwein-Teissl; K Zisterer; T L Schmitt; R Glück; S Cryz; B Grubeck-Loebenstein
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

9.  Effect of influenza immunization on CYP3A4 activity in vivo.

Authors:  Mary S Hayney; Daniel Muller
Journal:  J Clin Pharmacol       Date:  2003-12       Impact factor: 3.126

10.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory.

Authors:  J L Virelizier; R Postlethwaite; G C Schild; A C Allison
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.